Table 3.
Neuropsychiatric drugs taken by each patient during the study.
| Case # | OM in use before CE treatment | OM in use after CE treatment | Summary of changes in OM | CE side effects |
|---|---|---|---|---|
| 01f | None | None | No OM | None |
| 02m | Risperidone + Melatonin | None | Complete withdrawal | None |
| 03m | None (used oxcarbazepine before the study) | None | No OM | None |
| 04m | None | None | No OM | Nocturia and polyuria |
| 05f | None (used several OM before the study) | None | Complete withdrawal | None |
| 06m | None | None | No OM | Hyperaemia, sleepiness, and transient increase in core temperature |
| 07m | Promethazine + Risperidone | Risperidone | Partial withdrawal | Transient sleepiness |
| 08f | Melatonin + Risperidone | Risperidone | Partial withdrawal + dosage reduction | Slight increase in appetite |
| 09m | Oxcarbazepine + Risperidone + Levomepromazine | Oxcarbazepine + Risperidone + Levomepromazine | None | None |
| 10m | None | None | No OM | None |
| 11m | Carbamazepine + Risperidone | Risperidone | Partial withdrawal + dosage reduction | Transient diarrhea at treatment onset |
| 12m | Phenobarbital | Phenobarbital | Complete withdrawal | Nocturia |
| 13f | Lamotrigine + Topiramate | Lamotrigine + Topiramate | Dosage reduction | Sleepiness and mild irritation |
| 14m | Oxcarbazepine + Levetiracetam + Topiramate + Valproate semisodium + Risperidone | Topiramate + Risperidone | Partial withdrawal + dosage reduction | Transient sleepiness and mild irritation when waking up |
| 15m | Risperidone + Oxcarbazepine | Risperidone + Oxcarbazepine | Dosage reduction | None |
OM, alterations in other prescribed medication after introduction of CE (unaltered: no changes in the use of other medication was made; reduction, reduced the dosage of one or more medication; partial withdrawal, stopped completely the use of one of the medications; withdrawal, stopped completely the use of all other medication with the exception of CE.
f
female patients;
m
male patients.